SCHEMBL2720155

SCHEMBL2720155

CC(C)(C)[Si](C)(C)OCC(=O)Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20438667 0.82 DUT (0.40) —
SCHEMBL1085871 0.81 MAPT (0.33) —
SCHEMBL1876097 0.81 BACE1 (0.31) —
SCHEMBL9163997 0.79 BACE1 (0.30) —
SCHEMBL2163046 0.79 TSHR (0.40) —
SCHEMBL28790081 0.78 MAPT (0.31) —
SCHEMBL10702400 0.78 TSHR (0.36) —
SCHEMBL6470838 0.78 — —
SCHEMBL22033623 0.77 — —
SCHEMBL8451321 0.77 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 81 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005082892-A2 TRIAZOLE COMPOUNDS AS ANTIBACTERIAL AGENTS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM DR. REDDY'S LABORATORIES LTD. (IN) 2005-09-09 — — WO claimed
CN-119591621-A Novel ecteinascidin derivatives, preparation method and application thereof, antibody drug conjugate and application thereof 泰诚思(上海)生物医药有限公司 2025-03-11 — — CN disclosed
EP-3773563-B1 PRODRUGS OF FUSED-BICYCLIC C5AR ANTAGONISTS CHEMOCENTRYX INC (US) 2024-10-16 — — EP disclosed
CN-111954525-B Prodrugs of fused bicyclic C5aR antagonists 凯莫森特里克斯股份有限公司 2023-12-26 — — CN disclosed
US-11608336-B2 Prodrugs of fused-bicyclic C5aR antagonists CHEMOCENTRYX, INC. (US) 2023-03-21 — — US disclosed
CN-111393444-B Preparation method of abacavir hydroxy acetate 上海迪赛诺化学制药有限公司 2022-10-28 — — CN disclosed
EP-3448853-B1 COMPOUNDS FOR MODULATING AQUAPORINS APOGLYX AB (SE) 2021-11-17 — — EP disclosed
EP-3448853-B1 COMPOUNDS FOR MODULATING AQUAPORINS APOGLYX AB (SE) 2021-11-17 — — EP disclosed
US-20210052612-A1 PRODRUGS OF FUSED-BICYCLIC C5aR ANTAGONISTS CHEMOCENTRYX, INC. 2021-02-25 — — US disclosed
CN-111954525-A Prodrugs of fused bicyclic C5aR antagonists 凯莫森特里克斯股份有限公司 2020-11-17 — — CN disclosed
US-4920148-A C-29 oximinomilbemycin CIBA-GEIGY CORPORATION (US) 1990-04-24 — — US disclosed
US-4897416-A 5-OXIMINO-13B-CARBONYLTHIOMILBEMYCIN DERIVATIVES CIBA-GEIGY CORPORATION (US) 1990-01-30 — — US disclosed
US-4871719-A MILBEMYCIN CIBA-GEIGY CORPORATION (US) 1989-10-03 — — US disclosed
US-4855317-A Insecticides and parasiticides CIBA-GEIGY CORPORATION (US) 1989-08-08 — — US disclosed
EP-0074758-B1 4A-SUBSTITUTED AVERMECTIN COMPOUNDS, THEIR PRODUCTION AND ANTIPARASITIC USE, AND COMPOSITIONS CONTAINING THEM MERCK & CO. INC. (US) 1986-07-16 — — EP disclosed
US-4550160-A Processes for the interconversion of C-076 compounds MERCK & CO., INC. (US) 1985-10-29 — — US disclosed
EP-0040913-B1 23-KETO DERIVATIVES OF C-076 COMPOUNDS, THEIR PREPARATION AND ANTI-PARASITIC USE MERCK & CO. INC. (US) 1984-07-25 — — EP disclosed
US-4328335-A PARASITICIDES, CULTURE PRODUCT OF STREPTOMYCES REACTED WITH A THIOCARBONYL HALIDE MERCK & CO., INC. (US) 1982-05-04 — — US disclosed
EP-0040913-A1 23-Keto derivatives of C-076 compounds, their preparation and anti-parasitic use MERCK & CO. INC. (US) 1981-12-02 — — EP disclosed
US-4289760-A ANTHELMINTICS, PARASITICIDES MERCK & CO., INC. (US) 1981-09-15 — — US disclosed
Send feedback